Effect of WAY-100135 on the hippocampal acetylcholine release potentiated by 8-OH-DPAT, a serotonin,, receptor agonist, in normal and p-chlorophenylalanine-treated rats as measured by in vivo microdialysis

Neuroscience Research

Volumn 31, Issue 1, 1998, Pages 23-29

  Nakai, Katsuhiko ^a   Fujii, Takeshi ^a   Fujimoto, Kazuko ^a   Suzuki, Takeshi ^a   Kawashima, Koichiro ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

(+)WAY 100135; 8 hydroxy 2 (di n propylamino)tetralin; Acetylcholine; Hippocampus; Microdialysis; Radioimmunoassay; Serotonin(1A) receptor

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ACETYLCHOLINE; FENCLONINE; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; SEROTONIN; SEROTONIN 1A RECEPTOR;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ACETYLCHOLINE; ANIMALS; ENZYME INHIBITORS; FENCLONINE; HIPPOCAMPUS; MALE; MICRODIALYSIS; MOTOR ACTIVITY; PIPERAZINES; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; TRYPTOPHAN HYDROXYLASE;

EID: 0031841180     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-0102(98)00019-4     Document Type: Article

References (39)

1. Benveniste H., Drejer J., Schousboe A., Diemer N.H. Regional cerebral glucose phosphorylation and blood flow after insertion of a microdialysis fiber through the dorsal hippocampus in the rat. J. Neurochem. 49:1987;729-734.
2. Bianchi C., Siniscalchi A., Beani L. 5-HT1A agonists increase and 5-HT3 agonists decrease acetylcholine efflux from the cerebral cortex of freely-moving guinea-pigs. Br. J. Pharmacol. 101:1990;448-452.
3. Brodkin J., Malyala A., Nash F. Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity. Pharmacol. Biochem. Behav. 45:1993;647-653.
4. Cervo L., Grignaschi G., Samanin R. 8-Hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist, reduces the immobility of rats in the forced swimming test by acting on the nucleus raphe dorsalis. Eur. J. Pharmacol. 158:1988;53-59.
5. 1A receptors. J. Med. Chem. 36:1993;1509-1510.
6. Consolo S., Bertorelli R., Russi G., Zambelli M., Ladinsky H. Serotonergic facilitation of acetylcholine release in vivo from rat dorsal hippocampus via serotonin 5-HT3 receptors. J. Neurochem. 62:1994;2254-2261.
7. 1A-mediated facilitation of in vivo acetylcholine release in rat frontal cortex. Brain Res. 707:1996;320-323.
8. Dilsaver S. Cholinergic mechanisms in depression. Brain Res. Rev. 11:1986;285-316.
9. Farr R.S. A quantitative immunochemical measure of the primary interaction between I*BSA and antibody. J. Infect. Dis. 103:1958;239-262.
10. 1A receptor antagonists: utility as research tools and therapeutic agents. Trends Pharmacol. Sci. 14:1993;441-448.
11. 1A receptors. Eur. J. Pharmacol. 237:1993;283-291.
12. Fujii T., Yoshizawa M., Nakai K., Fujimoto K., Suzuki T., Kawashima K. Demonstration of the facilitatory role of 8-OH-DPAT on cholinergic transmission in the rat hippocampus using in vivo microdialysis. Brain Res. 761:1997;244-249.
13. Gillet G., Ammor S., Fillon G. Serotonin inhibits acetylcholine release from rat striatum slices: evidence for a presynaptic receptor-mediated effect. J. Neurochem. 45:1985;1687-1691.
14. 3H-dopa in various regions of the brain. J. Neurochem. 13:1966;655-669.
15. Hjorth S., Sharp T. Mixed agonist/antagonist properties of NAN-190 at 5-HT1A receptors: behavioural and in vivo brain microdialysis studies. Life Sci. 46:1990;955-963.
16. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., Saxena P.R., Humphrey P.P.A. VII. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46:1994;157-203.
17. Ishii Y., Kojima J., Ikeda N., Kawashima K. Effect of NIK-247 on basal concentrations of extracellular acetylcholine in the cerebral cortex of conscious, freely moving rats. Jpn. J. Pharmacol. 66:1994;289-293.
18. 1A receptor enhances acetylcholine release in conscious rats. J. Neurochem. 62:1994;1804-1808.
19. Kalkman H.O., Soar J. Determination of the 5-HT receptor subtype involved in 8-OH-DPAT-induced hyperlocomotion: potential difficulties arising from inadequate pharmacological tools. Eur. J. Pharmacol. 191:1990;383-390.
20. Kawashima K., Ishikawa H., Mochizuki M. Radioimmunoassay for acetylcholine in the rat brain. J. Pharmacol. Methods. 3:1980;115-123.
21. Kawashima K., Hayakawa T., Kashima Y., Suzuki T., Fujimoto K., Oohata H. Determination of acetylcholine release in the striatum of anesthetized rats using in vivo microdialysis and a radioimmunoassay. J. Neurochem. 57:1991;882-887.
22. Kawashima K., Sato A., Yoshizawa M., Fujii T., Fujimoto K., Suzuki T. Effects of the centrally acting cholinesterase inhibitors tetrahydroaminoacridine and E2020 on the basal concentration of extracellular acetylcholine in the hippocampus of freely moving rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 350:1994;523-528.
23. Koe B.K., Weissman A. p-Chlorophenylalanine: a specific depletor of brain serotonin. J. Pharmacol. Exp. Ther. 154:1966;499-516.
24. Maura G., Raiteri M. Cholinergic terminals in rat hippocampus possess 5-HT1B receptors mediating inhibition of acetylcholine release. Eur. J. Pharmacol. 129:1986;333-337.
25. Maura G., Fedele E., Raiteri M. Acetylcholine release from rat hippocampus slices is modulated by 5-hydroxytryptamine. Eur. J. Pharmacol. 165:1989;173-179.
26. Mead J.A.R., Finger K.F. A single extraction method for the determination of both norepinephrine and serotonin in brain. Biochem. Pharmacol. 6:1961;52-53.
27. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates, 2nd edn. Academic Press, Sydney.
28. 1A receptor-mediated hyperpolarization of the rat isolated superior cervical ganglion. Naunyn-Schmiedeberg's Arch. Pharmacol. 34:1993;225-227.
29. 1A and muscarinic acetylcholine receptors jointly regulate passive avoidance behavior. Eur. J. Pharmacol. 262:1994;77-90.
30. 1A receptor antagonist WAY100135: an in vivo microdialysis study. Eur. J. Pharmacol. 239:1993;195-202.
31. Routledge C., Gurling J., Ashworth-Preece M.A., Dourish C.T. Differential effects of WAY-100135 on the decrease in 5-hydroxytryptamine release induced by buspirone and NAN-190. Eur. J. Pharmacol. 276:1995;281-284.
32. 1A agonists. J. Pharmacol. Exp. Ther. 270:1994;198-208.
33. Siniscalchi A., Beani L., Bianchi C. Different effects of 8-OH-DPAT, a 5-HT1A receptor agonist, on cortical acetylcholine release, electrocortigram and body temperature in guinea pigs and rats. Eur. J. Pharmacol. 175:1990;219-223.
34. 1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. Eur. J. Pharmacol. 106:1985;271-282.
35. 1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats. J. Neurosci. 6:1986;3474-3482.
36. Wallenstein S., Zucker C.L., Fleiss J.L. Some statistical methods useful in circulation research. Circ. Res. 47:1980;1-9.
37. Westerink B.H.C., Hofsteede H.M., Damsma G., de Vries J.B. The significance of extracellular calcium for the release of dopamine, acetylcholine and amino acids in conscious rats, evaluated by brain microdialysis. Naunyn-Schmiedeberg's Arch. Pharmacol. 337:1988;373-378.
38. Wieland S., Lucki I. Antidepressant-like activity of 5-HT1A agonists measured with the forced swim test. Psychopharmacology. 101:1990;497-504.
39. 1A receptor activation increases hippocampal acetylcholine efflux and motor activity in the guinea pig: agonist efficacy influences functional activity in vivo. J. Pharmacol. Exp. Ther. 270:1994;656-664.